Parámetros hematológicos y laboratoriales tempranos asociados con la mortalidad por COVID-19 en una población amazónica del Perú
DOI:
https://doi.org/10.35434/rcmhnaaa.2022.154.1529Palabras clave:
Coronavirus-2019, 2019-nCoV, COVID-19, SARS-CoV-2, Hallazgos de laboratorio, Pronóstico; DiagnósticoResumen
COVID-19 tiene un impacto significativo en el sistema hematopoyético y la hemostasia. La leucocitosis, la linfopenia y la trombocitopenia se asocian con una mayor gravedad e incluso la muerte en los casos de COVID-19. Objetivo: examinar los resultados de laboratorio de pacientes con COVID-19 de un hospital de la Amazonía peruana y su pronóstico clínico. Material y métodos: Se realizó un estudio transversal analítico cuyo propósito fue identificar las pruebas de laboratorio de pacientes con COVID-19 y mortalidad en un hospital de Ucayali, Perú durante el periodo del 13 de marzo al 9 de mayo del 2020, seleccionando un total de 127 con COVID-19. Se describió la media y la desviación estándar para edad, leucocitos, neutrófilos, plaquetas, RDW-SD; mediana y rango intercuartílico para las variables linfocito, RN/L, fibrinógeno, PCR, dímero D, DHL, hematocrito, monocitos, eosinófilos. Resultados: No se observaron diferencias en esta población en cuanto a muerte y sexo (OR: 1,31; IC 95% 0,92 a 1,87), sin embargo, se observó que, por cada aumento de un año, la probabilidad de muerte aumentaba un 4% (RP: 1,04). , IC del 95%: 1,03 a 1,05). El análisis de RIR (Razón de incidencia de riesgos) para las variables numéricas mostró resultados fuertemente asociados con valores hematológicos como Leucocitos (escala de 2500 unidades) (RRI: 1.08, 95% CI 1.03 a 1.13), neutrófilos (escala de 2500 unidades) (RRI: 1.08; IC 95% 1.03 a 1.13), por el contrario, se observa que al aumento de 1000 unidades en linfocitos, la probabilidad de morir disminuyó en un 48% (TIR: 0.52; IC 95% 0.38 a 071). Conclusiones: Parámetros tales como los leucocitos, los neutrófilos y el dímero D fueron estadísticamente mucho más altos en los pacientes que fallecieron.
Descargas
Métricas
Citas
Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, et al. Fair Allocation of Scarce Medical Resources in the Time of Covid-19. N Engl J Med [Internet]. 2020 May 21 [cited 2022 Apr 25];382(21):2049–55. Available from: https://www.nejm.org/doi/full/10.1056/nejmsb2005114. DOI: 10.1056/NEJMsb2005114
Peru COVID - Coronavirus Statistics - Worldometer [Internet]. [cited 2022 Apr 25]. Available from: https://www.worldometers.info/coronavirus/country/peru
Álvarez-Antonio C, Meza-Sánchez G, Calampa C, Casanova W, Carey C, Alava F, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study. Lancet Glob Heal. 2021 Jul 1;9(7):e925–31. DOI:https://doi.org/10.1016/S2214-109X(21)00173-X
Díaz-Vélez C, Failoc-Rojas VE, Valladares-Garrido MJ, Colchado J, Carrera-Acosta L, Becerra M, et al. SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June–July 2020. PeerJ [Internet]. 2021 Apr 6 [cited 2022 Apr 25];9:e11210. Available from: https://peerj.com/articles/11210. DOI: 10.7717/peerj.11210
Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MMG, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev. 2020 Jul;2020(7). DOI: 10.1002/14651858.CD013665
Halboub E, Al-Maweri SA, Alanazi RH, Qaid NM, Abdulrab S. Orofacial manifestations of COVID-19: a brief review of the published literature. Braz Oral Res. 2020;34. DOI: 10.1590/1807-3107bor-2020.vol34.0124
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020 May;115(5):766–73.
Makaronidis J, Mok J, Balogun N, Magee CG, Omar RZ, Carnemolla A, et al. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study. PLoS Med. 2020 Oct;17(10):e1003358. DOI: 10.1371/journal.pmed.1003358
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China [published correction appears in Intensive Care Med. 2020 Apr 6;:]. Intensive Care Med. 2020;46(5):846-848. . DOI: 10.1007/s00134-020-05991-x
Ioannidis JPA, Axfors C, Contopoulos-Ioannidis DG. Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters. Environ Res. 2020 Sep;188:109890. DOI: 10.1016/j.envres.2020.109890
Hasan SS, Capstick T, Ahmed R, Kow CS, Mazhar F, Merchant H a., et al. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020 Nov;14(11):1149–63. DOI: 10.1080/17476348.2020.1804365
Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020 Oct;36(7). DOI: 10.1002/dmrr.3319
Zaki N, Alashwal H, Ibrahim S. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review. Diabetes Metab Syndr Clin Res Rev. 2020 Sep;14(5):1133–42. DOI: 10.1016/j.dsx.2020.07.005
Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta. 2020;510:475-482. DOI:10.1016/j.cca.2020.08.019
Xie Y, Wang Z, Liao H, Marley G, Wu D, Tang W. Epidemiologic, Clinical, and Laboratory Findings of the COVID-19 in the current pandemic. Res Sq [Preprint]. 2020 May 28:rs.3.rs-28367. doi: 10.21203/rs.3.rs-28367/v1. Update in: BMC Infect Dis. 2020 Aug 31;20(1):640. DOI: 10.21203/rs.3.rs-28367/v1.
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020 Jul;95(7):834–47. DOI: 10.1002/ajh.25829
Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chem Lab Med. 2020 Jun;58(7):1021–8. DOI: 10.1515/cclm-2020-0369
Liu X, Zhang R, He G. Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann Hematol. 2020;99(7):1421-1428. DOI:10.1007/s00277-020-04103-5.
Organization WH. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization; 2020.
Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. Afrin F, editor. PLoS One. 2020 Aug;15(8 August):e0238160. DOI: 10.1371/journal.pone.0238160
Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170(4):1136–47. DOI: 10.2353/ajpath.2007.061088
Yuan X, Huang W, Ye B, Chen C, Huang R, Wu F, et al. Changes of hematological and immunological parameters in COVID-19 patients. Int J Hematol [Internet]. 2020 Oct 1 [cited 2020 Nov 15];112(4):553–9. Available from: https://doi.org/10.1007/s12185-020-02930-w. DOI: 10.1007/s12185-020-02930-w
Zhao Y, Nie HX, Hu K, Wu XJ, Zhang YT, Wang MM, et al. Abnormal immunity of non-survivors with COVID-19: Predictors for mortality. Infect Dis Poverty. 2020 Aug;9(1):108.DOI: 10.1186/s40249-020-00723-1
Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020 Jul;81(1):e6–12. DOI: 10.1016/j.jinf.2020.04.002
Hayiroglu MI, Cinar T, Tekkesin AI. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: Current literature review. Rev Assoc Med Bras. 2020 Jun;66(6):842–8. DOI: 10.1590/1806-9282.66.6.842
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr;18(4):844–7. DOI: 10.1111/jth.14768
Wang C, Deng R, Gou L, Fu Z, Zhang X, Shao F, et al. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Ann Transl Med. 2020 May;8(9):593–593. DOI: 10.21037/atm-20-3391
Mallapaty S. The coronavirus is most deadly if you are older and male-new data reveal the risks. Nature. 2020;16–7. DOI: 10.1038/d41586-020-02483-2
Lippi G, Favaloro EJ. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost. 2020 May;120(5):876–7. OI: 10.1055/s-0040-1709650
Descargas
Publicado
Cómo citar
Número
Sección
Categorías
Licencia
Derechos de autor 2023 Sebastián Iglesias-Osores, Arturo Rafael-Heredia, Eric R Rojas-Tello, Washington A Ortiz-Uribe, Walter R Leveau-Bartra, Orison A Leveau-Bartra, Lizbeth M Córdova-Rojas, Wagner Colmenares-Mayanga, Virgilio E Failoc-Rojas
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
